See All Slides - tctmd.com

Slides

Presentation TCT 2012

The Case for CT-FFR as the Optimal Screening Tool: Latest DEScover and DeFACTO Results

Presenter: Jonathon Leipsic

October 23, 2012

Presentation TCT 2012

Perspective 1

Presenter: Jeff Davis

October 23, 2012

Presentation TCT 2012

TCT-371. First Clinical Evaluation of a Novel Percutaneous Right Ventricular Assist Device: The Impella RP

Presenter: Anson Cheung

October 23, 2012

Presentation TCT 2012

When Do I Prefer PCI for MVD? The Surgeon's Perspective

Presenter: A. Pieter Kappetein

October 23, 2012

Presentation TCT 2012

No: Changing Standards Would Be Premature!

Presenter: Robert Siegel

October 23, 2012

Presentation TCT 2012

TCT-39. 6-month Angiographic Follow-up of the Novel DESolveTM Myolimus-eluting Bioresorbable Coronary Scaffold for the Treatment of Non-complex Coronary Lesions – Results from...

Presenter: Ricardo Costa

October 23, 2012

Presentation TCT 2012

ELM Presentation(6)

Presenter: Lynn Peng

October 23, 2012

Presentation TCT 2012

New Devices in the Old World: A European View of Device Development for Heart Failure

Presenter: Stefan Anker

October 23, 2012

Presentation TCT 2012

The New Fourth-Generation WATCHMAN (BSC-Atritech): Device Design and Results of the EVOLVE Trial

Presenter: Vivek Reddy

October 23, 2012

Presentation TCT 2012

TCT-36. Circumferential Distribution of the Neointima Tissue at 6 Months and 2 at Years Follow-up After a Bioresorbable Scaffold Implantation: A Serial Optical Coherence...

Presenter: Christos Bourantas

October 23, 2012

Advertisement

Slides

The Case for CT-FFR as the Optimal Screening Tool: Latest DEScover and DeFACTO Results

Perspective 1

TCT-371. First Clinical Evaluation of a Novel Percutaneous Right Ventricular Assist Device: The Impella RP

When Do I Prefer PCI for MVD? The Surgeon's Perspective

No: Changing Standards Would Be Premature!

TCT-39. 6-month Angiographic Follow-up of the Novel DESolveTM Myolimus-eluting Bioresorbable Coronary Scaffold for the Treatment of Non-complex Coronary Lesions – Results from...

ELM Presentation(6)

New Devices in the Old World: A European View of Device Development for Heart Failure

The New Fourth-Generation WATCHMAN (BSC-Atritech): Device Design and Results of the EVOLVE Trial

TCT-36. Circumferential Distribution of the Neointima Tissue at 6 Months and 2 at Years Follow-up After a Bioresorbable Scaffold Implantation: A Serial Optical Coherence...

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content